In the evolving landscape of patent law, the Doctrine of Equivalents has served as a pivotal mechanism allowing patent holders to safeguard their innovations against infringement. Our previous discussion delved into the nuances of this doctrine, exploring its significance in extending the protective reach of patents beyond their literal claims. As a natural progression, this blog examines the concept of Patent Prosecution History Estoppel, a critical limitation to the Doctrine of Equivalents.
Patent prosecution history estoppel serves as a fundamental doctrine in patent law that prevents patent owners from claiming broader protection during infringement litigation than what they secured during patent prosecution. This legal principle becomes particularly significant when patent owners attempt to use the doctrine of equivalents to expand their patent rights. The doctrine of equivalents traditionally allows patent holders to claim infringement even when a product does not literally infringe their patent claims, provided it performs substantially the same function in substantially the same way to achieve substantially the same result[1]. However, prosecution history estoppel acts as a crucial check on this expansion of rights. This legal principle serves a critical role in patent holders’ ability to assert their rights beyond the literal scope of their claims, especially when they have previously surrendered certain subject matter during patent prosecution[2].
Patent prosecution history estoppel prevents patent owners from recapturing through litigation what they gave up during prosecution. This limitation manifests in two primary ways: amendment-based estoppel and argument-based estoppel[3]. Amendment-based estoppel occurs when patent claims are narrowed through amendments made for patentability reasons. When such amendments are made, courts presume that the patentee has surrendered all territory between the original claim scope and the amended claim scope. This presumption can be rebutted in certain circumstances, such as when the patentee can show that the amendment was unrelated to patentability or that the equivalent was unforeseeable at the time of the amendment.
Argument-based estoppel, on the other hand, arises from arguments made to distinguish prior art during prosecution. When patent applicants make clear and unmistakable surrenders of subject matter through their arguments to patent examiners, they cannot later reclaim that subject matter through the doctrine of equivalents. Unlike amendment-based estoppel, argument-based estoppel typically cannot be rebutted once established[4].
When there is a conflict between the applications of these two principles, the patent prosecution estoppel is given priority. Applicants usually make amendments to claims or statements that limit and narrow the scope of claims in order to accommodate the patent law during patent prosecution. Adding new technical features to the independent claim, selecting technical features from the specification and adding them to the independent claim, or elevating a subordinate claim as a new independent claim are common methods of amendments in practice. These lead to the change of the scope of the independent claim and create a presumption that the owner surrendered all other processes, achieving the same result.
The United States Court of Appeals for the Federal Circuit’s decision in Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co. (2002)[5] provided crucial guidance on how prosecution history estoppel limits the doctrine of equivalents. The Court established that while narrowing amendments creates a presumption of estoppel, this presumption can be rebutted in specific circumstances. These include situations where the equivalent was unforeseeable at the time of the amendment, where the rationale for the amendment bears only a tangential relation to the equivalent, or where there was some other reason, the patentee could not have been expected to describe the equivalent.
Different jurisdictions handle the interplay between prosecution history estoppel and the doctrine of equivalents in varying ways. The United States maintains strong recognition of both doctrines, with a clear framework established by the Festo decision. European courts generally take a more limited approach to the doctrine of equivalents while considering prosecution history as one factor among many. Indian courts have shown increasing recognition of both doctrines in recent years, often following international precedents while developing their own jurisprudence.
The Vifor and Others v Virchow Biotech and Others[6] (2023) case before the Delhi High Court provides a compelling example to demonstrate the significant impact of prosecution history estoppel. The Delhi High Court clearly illustrates how prosecution history estoppel operates. The case involved a patent for water-soluble iron carbohydrate complexes, specifically Ferric Carboxy Maltose (FCM). During prosecution, Vifor had limited their claims to a specific process using aqueous hypochlorite as an oxidizing agent. When the defendants later manufactured FCM using a different oxidizing agent (Oxone), Vifor attempted to assert infringement. When Vifor attempted to assert broader protection through the doctrine of equivalents after having narrowed their claims during prosecution to overcome novelty objections, the court applied prosecution history estoppel to prevent the expansion of rights.
The court’s analysis hinged on a critical examination of the prosecution history. It found that Vifor had admitted during prosecution that iron carbohydrate complexes were already known, and their invention specifically resided in preparing these complexes using Maltodextrin and aqueous Hypochlorite as the oxidizing agents. The defendants’ use of Oxone instead of Hypochlorite provided significant advantages, including avoiding undesired chlorinated by-products and improving product purity. The Court provided as follows;
“73. No party can be permitted to approbate and reprobate at the same time and the prosecution history estoppel becomes pronounced on account of the fact that the patent was obtained by representing that the novel properties in the product were attributable to characteristic features of the process mentioned therein. There is wealth of judicial precedents, both in India and abroad, where prosecution history estoppel has been a well-recognized parameter to adjudicate issues pertaining to patents, particularly, at the stage of grant of interim injunctions, which is a discretionary relief and one of the factors that goes into the decision-making process is the conduct of the party seeking equitable relief. United States Court of Appeals for the Federal Circuit in Pharma Tech Solutions, Inc., Decision IT Corp. v. Lifescan, Inc., Lifescan Scotland, Ltd., decided on 22.11.2019, emphasized on the importance of prosecution history in the context of infringement analysis and the principle is well recognized by this Court in Astrazeneca AB and Ors. v. Intas Pharmaceuticals Ltd. and Ors., 2021 SCC OnLine Del 3746 and FMC Corporation and Others v. GSP Crop Science Private Limited, 2022 SCC OnLine Del 3784”
The court ultimately ruled against Vifor, holding that they could not claim infringement when the defendants used a different process, especially since Vifor had consciously limited their claims during prosecution to a specific oxidizing agent. The court noted that the stand taken by Vifor before the Controller of Patent during the prosecution of their patent was that “the essence of the present invention is that by appropriately selecting suitable maltodextrins having specific dextrose equivalent as defined in the claims”. This decision reinforces that patent owners seeking interim injunctions must demonstrate that the rival process is identical to their asserted process, particularly in product-by-process claims. To preserve the rights under the doctrine of equivalents, patent owners must adopt careful strategies from the earliest stages of patent prosecution. This includes drafting claims to minimize the need for amendments, making only necessary amendments during prosecution, and maintaining detailed records of the reasons for any changes. Continuing applications should be considered to maintain broader protection where possible, and potential equivalent technologies should be contemplated during the drafting process.
The relationship between prosecution history estoppel and the doctrine of equivalents continues to evolve as courts balance the rights of patent owners with the public need for clarity of patent boundaries. This evolution emphasizes the importance of considering potential equivalents early in the patent process and managing prosecution history carefully to ensure robust patent protection. The key takeaway is that any amendment or argument presented during prosecution can limit the ability to claim infringement under the doctrine of equivalents. This highlights the need for strategic foresight and diligent prosecution management to maintain strong patent protection.
The content on this blog is for informational purposes only and does not constitute legal advice. Images generated by AI.
[1] James, N. (2024). DOCTRINE OF EQUIVALENTS AND PATENT INFRINGEMENT – AN ANALYSIS THROUGH THE LENS OF THE INDIAN JUDICIARY. puthrans.com. https://www.puthrans.com/doctrine-of-equivalents-and-patent-infringement-an-analysis-through-the-lens-of-the-indian-judiciary/
[2] Analysis Of Patent prosecution History Estoppel And Its Use In The Doctrine Of Equivalents | IIPRD. https://www.iiprd.com/analysis-of-patent-prosecution-history-estoppel-and-its-use-in-the-doctrine-of-equivalents/
[3] Saraswat, A. (2022). Analysis Of Patent Prosecution History Estoppel And Its Use In The Doctrine Of Equivalents. Mondaq – Law Articles and Insights. https://www.mondaq.com/india/patent/1170034/analysis-of-patent-prosecution-history-estoppel-and-its-use-in-the-doctrine-of-equivalents
[4] Ibid
[5] 535 U.S. 722 (2002)
[6] CS(COMM) 450/2022, Vifor International Ltd. and Ors. vs. MSN Laboratories Private Limited and Ors. (24.07.2023 – DELHC): MANU/DE/4760/2023
